IQVIA - Pulmonary Clinical Trials

Research Insights

The Research Insights area highlights recent advances in science and medicine as well as global laboratory research. Our readers gain tremendous benefit from research discoveries in an indirect manner.

Limited efficacy of a therapeutic anti-CD40 monoclonal antibody to inhibit activated CD4 T cell autoimmunity in vitro

Iscalimab is a nondepleting antiCD monoclonal antibody expected to suppress immune responses by blocking the costimulation by antigenpresenting cells through CDCDL ligation

Barrier-to-autointegration factor protects against the cGAS-STING response to chromatin bridges

Cellular damage or stress can lead to disorganization mislocalization or damage to selfDNA that can activate intracellular innate immune response mechanisms Micronuclei such as can occur following mitotic defects

A simple model captures key characteristics of biological non-deterministic genotype-phenotype maps

By connecting genotypic mutations to the higherlevel phenotypes relevant for selection genotypephenotype GP maps play a key role in evolution GP maps are typically investigated using computational models

Uncovering the mechanisms of synergistic drug combinations in non-small cell lung cancer through metagene-based classification

Drug resistance remains a significant challenge in treating nonsmall cell lung cancer NSCLC Identifying synergistic

Measurement properties of the 30-second sit-to-stand test in post COVID-19 condition: Results from the PYCNOVID randomised controlled trial

The second sittostand test sSTS is a frequently used measure of functional capacity in postCOVID condition PCC but its measurement properties have not been comprehensively investigated

Methods for analytical validation of novel digital clinical measures: A simulation study

Analytical validation is a crucial step in the evaluation of algorithms that process data from sensorbased digital health technologies sDHTs Analytical validation of novel digital measures can be complicated when reference

Computational modeling of intravitreal ranibizumab kinetics: Predicting macular drug concentration and half-life

Ranibizumab is a key antiVEGF therapeutic used to improve treatment efficacy and reduce injection frequency in neovascular retinal diseases Because experimental pharmacokinetic data in humans are limited

Interpretable multivariate survival models: Improving predictions for conversion from mild cognitive impairment to Alzheimer’s disease via data fusion and machine learning

Accurately predicting which individuals with mild cognitive impairment MCI will progress to Alzheimers disease AD can improve patient care This study examines the role of quantitative MRI qMRI cognitive evaluations

A comparative study of organoid-derived and cell line-derived intestinal epithelial models

In vitro intestinal epithelial models are being developed for studying gut physiology barrier function and drug transport There are two major in vitro models which are currently used cell linederived monolayers

Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types

The allergeninduced latephase asthmatic response LAR is used to study the mechanisms and treatment of asthma We hypothesized that geneexpression mRNA biomarkers of the LAR may